Recipient Epidemiology and Donor Evaluation Study-III

Institution(s): 
Vitalant Research Institute
Approx. Sample Size to be Sequenced: 
2809
Populations: 

Brazilian

Project:

Disease/Phenotype: 

sickle cell disease

PI: 
Brian Custer
NIH Program Officer: 
Starting Phase: 
Phase 2
Phases Involved: 
2
Co-PI: 
Shannon Kelly
Sequencing Center Contact: 
Phenotype Liaison: 
Data Set contact(s): 
Short Name: 
REDS-III_Brazil
Sequencing Center(s) Phase 2: 
Baylor College of Medicine Human Genome Sequencing Center
Type of Sequencing: 
WGS
Sequencing External Funding: 
TOPMed Accession #: